SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Jun-22 4:46 PM View: | Agile Therapeutics, Inc. (AGRX) | 09-Jun-22 | Grant | 670 | -- | -- | 43% 1.57K to 2.24K | |
10-Jun-21 7:10 PM View: | Agile Therapeutics, Inc. (AGRX) | 08-Jun-21 | Grant | 24,510 | -- | -- | 64% 38.34K to 62.85K | |
11-Jun-20 5:21 PM View: | Agile Therapeutics, Inc. (AGRX) | 09-Jun-20 | Grant | 13,393 | -- | -- | 54% 24.95K to 38.34K | |
08-Jun-18 5:00 PM View: | Agile Therapeutics, Inc. (AGRX) | 08-Jun-18 | Option Exercise | 17,949 | -- | -- | 256% 7.0K to 24.95K | |
01-Mar-18 7:08 AM View: | Actinium Pharmaceuticals, I... (ATNM) | 28-Feb-18 | Purchase | 22,730 | $0.43 | $9,773.90 | 100% 0 to 22.73K | |
14-Jun-17 4:30 PM View: | Agile Therapeutics, Inc. (AGRX) | 12-Jun-17 | Option Exercise | 7,000 | $3.75 | $26,250.00 | 100% 0 to 7.0K | (80%) |